Anne W. Beaven, MD

Anne W. Beaven, MD, Director, Lymphoma Program, Associate Professor of Medicine

Anne Beaven

Anne W. Beaven, MD, is the Director of UNC Lineberger's Lymphoma Program. She is involved in caring for patients as well as overseeing the development of our research protocols and guiding the growth of our program in order to best serve our patients with lymphoma. Since 2007, Dr. Beaven’s research and clinical work have focused on the care of patients with all types of Hodgkin and non-Hodgkin lymphoma, both aggressive and indolent varieties.

She is particularly interested in the management of systemic T cell non-Hodgkin lymphoma (PTCL) and cutaneous lymphomas. Cutaneous lymphoma is a subtype of lymphoma that primarily involves the skin; the most common type is a cutaneous T cell lymphoma (CTCL) called mycosis fungoides. In order to better serve this patient population, she is working with Edith Bowers, MD, PhD, a UNC dermatologist, to establish a multi-disciplinary clinic to take care of these complicated patients who often need a combination of treatment approaches.

Beaven’s research will focus on developing clinical trials for patients with systemic and cutaneous lymphomas. In particular she will work with UNC Lineberger to continue to grow our chimeric antigen receptor (CAR) T cell therapy that harnesses the patient’s own immune system to fight their cancer. She will also be developing some trials to determine the best treatments for the very old (>80 years) patients with lymphoma, a group that is historically underserved.

She works hard with our team of physicians, nurse practitioners, physician assistants, pathologists, radiologists, radiation oncologists, and pharmacists to make sure that lymphoma patients at UNC get the best care possible.